Watch Webinar: Where in the world should I locate my pivotal clinical trial?

If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP. 

Watch our video: Navigating an era of uncertainty

We are pleased to share with you our new video Cromos Pharma: Helping to navigate an era of uncertainty.

Webinar: Where in the world should I locate my pivotal clinical trial?

EU cancer estimates for 2020 reveal 2.7 million new cases

The European Joint Research Council released its 2020 burden of cancer estimates on 22 July, 2020. The report revealed The cancer burden is estimated to have risen to 2.7 million new cases (all types, excluding non-melanoma skin cancer) and 1.3 million deaths in 2020. Female breast cancer remains the most commonly diagnosed.

FDA proposes new rule on reporting requirements to support Right to Try

On July 23, the U.S. Food and Drug Administration (FDA) announced a new proposed rule that would require sponsors and manufacturers who provide an ‘‘eligible investigational drug’’ under the Right to Try Act to submit an annual summary of such use to FDA.

European medicines agencies launch public consultation on joint strategy

The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have developed a joint strategy for the next five years. It was released for a two-month public consultation period on 6, July, 2020.

Two new reports find impacts of COVID-19 on clinical trials easing slightly

Two new reports released by GlobalData Healthcare and Medidata find evidence of COVID-19 impacts on clinical trials easing slightly. 

Risk Based Monitoring- a data-centric approach to monitoring

In this Insights@CromosPharma article our Chief Operating Officer Stephanie Finnegan explores the role of Risk Based Monitoring (RBM) in clinical trials, how it has been utilized in response to the current coronavirus pandemic, and how the experience may shape the industry's approach to RBM in the future.

Cromos Pharma Recruits over 300 Patients in Under Two Months into a COVID-19 Clinical Trial

Cromos Pharma, an international CRO, is pleased to announce unprecedented recruitment in a phase IIb trial in patients with moderate to severe COVID-19 infection.

Connect with Cromos Pharma at BIO Digital 2020

Cromos Pharma is delighted to be participating in BIO Digital 2020, June 8-12 2020. 

Cromos Pharma celebrates International Clinical Trials Day 2020

Today (20 May, 2020) marks International Clinical Trials Day 2020. Cromos Pharma wishes to express its gratitude to everyone who participates in  and conducts clinical trials that help turn research into reality and make lifesaving and life-changing medical treatments available to patients all over the world.

First patients enrolled in Cromos Pharma managed Covid-19 trial

Cromos Pharma is proud to be part of the global search for effective COVID-19 treatments. Today (24 April, 2020) we are pleased to announce the enrollment of the first patients in clinical trials designed to be find drugs to treat the symptoms of coronavirus.

Cromos Pharma insights on master protocols

Master protocols are disrupting the clinical trial space by offering a more comprehensive and adaptive approach to studying treatments for the most complex of diseases. Cromos Pharma is delighted to share with you a recently published article on the topic by CEO Dr Vlad Bogin.

Cromos Pharma supporting World Immunization Week

Vaccines are some of our most powerful weapons against deadly diseases. Cromos Pharma salutes all those involved in the development, administration and promotion of vaccines all over the world.

Cromos Pharma wishes you a safe and healthy Easter and Passover

At the most difficult time, the entire Cromos Pharma Team wishes all our patients, clients, investigators, site personnel and partners a safe and healthy Easter and Passover.

European Medicines Agency launches new regulatory science strategy

The European Medicines Agency (EMA) recently (31 March 2020) published its Regulatory Science Strategy to 2025. The strategy provides a plan for advancing regulatory science over the next five years, covering both human and veterinary medicines.

Cromos Pharma to run COVID-19 trial

Cromos Pharma is pleased to announce that it has been enlisted to run a clinical trial of a repurposed drug candidate to treat COVID-19.  

Cromos Pharma committed to delivering in the face of COVID-19 challenges

Cromos Pharma has been closely following the COVID-19 outbreak as it continues to spread across the globe.

Cromos Pharma launches new series to explore the latest developments in clinical trials sector

2020 marks the start of a new decade when we can anticipate several trends to take hold in the global clinical research market. What can we expect in terms of the market in terms of growth and trends? Throughout 2020 Cromos Pharma’s team of experts will look at some of the major trends dominating the current market and future influences on clinical research.

Celebrating the Women of Cromos Pharma on IWD 2020

On the occasion of International Women’s Day (8 March 2020) we at Cromos Pharma are celebrating the enormous contribution of our female team members.

Cromos Pharma launches a new office in Warsaw, Poland

Cromos Pharma, an international provider of clinical trial and drug development services, today (04 MARCH 2020) announced the opening of its new office in Warsaw, Poland. The opening of the new office strengthens Cromos Pharma’s position in Poland where it has been operational since 2015.

“The establishment of the Poland office is a major development in line with Cromos Pharma’s continued expansion in European and US operations marking another milestone in the sustained growth of the Company. Poland is a significant clinical trials market that has many advantages making it highly attractive to international sponsors,” said Dr. Vlad Bogin, CEO, Cromos Pharma, “Cromos Pharma looks forward to offering sponsors an extended range of our expert services through its new office to ensure effective and cost-efficient execution of clinical trials”.

With its 40 million people Poland is one of the largest clinical trials markets in Eastern Europe that has a strong track record of over 20 years in delivering high-quality research. It boasts several advantages including a large naïve population and well-developed research infrastructure. Polish patients are positively disposed to taking part in clinical trials as it offers them an opportunity to access innovative treatments otherwise not always available to them. The country has a large network of highly skilled and motivated clinical investigators and medical professionals keen to participate in clinical research. Poland also offers relatively low costs and excellent patient recruitment.

With excellent rates of patient recruitment, high-quality data, highly skilled and committed investigators, and comparatively low costs, Poland is an attractive location for sponsors. Cromos Pharma is ready to help you access these advantages through our excellent knowledge of the regulatory processes and our existing relationships with sites and investigators.

Learn more about conducting clinical trials in Poland with Cromos Pharma here.

To explore these advantages and the services Cromos Pharma can offer you please email bd@cromospharma.com.

About Cromos Pharma

Cromos Pharma is an international Contract Research Organization (CRO) providing tailored and effective clinical trials management to support the development of drugs that transform healthcare. It offers fully integrated services with expertise in all aspects of clinical trials of all phases in a wide range of therapeutic indications. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management. Cromos Pharma has an extensive network of offices across 15 countries and strong regional experience in Central and Eastern Europe. Its European HQ is situated in Dublin, Ireland and its US base is in Portland, Oregon with an operational base in South Florida.

Cromos Pharma attends Asia Matters briefing

Thank you for your business and support throughout 2019. We look forward to working with you in 2020!

On behalf of everyone at Cromos Pharma I would like to wish our clients and partners a very happy and healthy holiday season. Thank you for your business and support throughout 2019. We look forward to working with you in 2020!

Meet Cromos Pharma’s CEO at the 38th Annual J.P Morgan Healthcare Conference

Meet Cromos Pharma at 61st ASH Annual Meeting & Exposition

Thanksgiving Message

Our medical writing team is focused on delivering the results you need.

Cromos Pharma celebrating 15 years of excellence in clinical research

Join us at ESMO in Barcelona on September 27 - October 1, 2019

Meet us at Outsourcing in Clinical Trials Pacific Northwest in Seattle on October 16 - 17 2019

Meet the Cromos Pharma team at the 2019 KoNECT-MOHW-MFDS International Conference to be held on September 17 – 19 in Seoul, South Korea.

Cromos Pharma CEO highlights opportunities and challenges for small sponsors at MAGI Clinical Research Conference

Cromos Pharma sets a new record in site initiation timelines in Poland

Cromos Pharma's "Your Perfect CRO" Survey shows surprising results

Cromos Pharma recruits 473 patients (92% of total) into a breast cancer trial, all in under 7 months.